<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Farnham Dene Medical Practice</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+H81615">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Farnham Dene Medical Practice is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0301030B0&amp;denomIds=3.1.3&amp;selectedTab=summary">Aminophylline</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Theophylline</td>&#13;
      <td>18</td>&#13;
      <td>0.06</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>97.32</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0301030B0AAABAB&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Aminophylline 250mg/10ml solution for injection ampoules : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1501030D0&amp;denomIds=15.1.3&amp;selectedTab=summary">Atropine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Antimuscarinic drugs</td>&#13;
      <td>1</td>&#13;
      <td>1.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.04</td>&#13;
      <td>22.21</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1501030D0AAAPAP&amp;denomIds=15.1.3&amp;selectedTab=summary" target="_blank">Atropine 600micrograms/1ml solution for injection ampoules : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0406000R0&amp;denomIds=4.6&amp;selectedTab=summary">Nabilone</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>5</td>&#13;
      <td>Drugs used in nausea and vertigo</td>&#13;
      <td>518</td>&#13;
      <td>0.01</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>18.35</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0406000R0AAAAAA&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Nabilone 1mg capsules : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0107010S0&amp;denomIds=1.7.1&amp;selectedTab=summary">Sucralfate</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Soothing haemorrhoidal preparations</td>&#13;
      <td>3</td>&#13;
      <td>0.33</td>&#13;
      <td>0.0</td>&#13;
      <td>0.02</td>&#13;
      <td>17.51</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0107010S0AAAKAK&amp;denomIds=1.7.1&amp;selectedTab=summary" target="_blank">Sucralfate 2g/20ml enema : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1001022G0&amp;denomIds=10.1.2&amp;selectedTab=summary">Hydrocortisone acetate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Local corticosteroid injections</td>&#13;
      <td>29</td>&#13;
      <td>0.03</td>&#13;
      <td>0.0</td>&#13;
      <td>0.00</td>&#13;
      <td>16.71</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1001022G0BBABAE&amp;denomIds=10.1.2&amp;selectedTab=summary" target="_blank">Hydrocortistab 25mg/1ml suspension for injection ampoules : 1</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Farnham Dene Medical Practice is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1312000C0&amp;denomIds=13.12&amp;selectedTab=summary">Aluminium chloride</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>2</td>&#13;
      <td>Antiperspirants</td>&#13;
      <td>3</td>&#13;
      <td>0.67</td>&#13;
      <td>0.99</td>&#13;
      <td>0.06</td>&#13;
      <td>-5.38</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1312000C0AAASAS&amp;denomIds=13.12&amp;selectedTab=summary" target="_blank">Aluminium chloride 20% solution : 2</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0409020S0&amp;denomIds=4.9.2&amp;selectedTab=summary">Procyclidine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>30</td>&#13;
      <td>Antimuscarinic drugs used in parkinsonism</td>&#13;
      <td>87</td>&#13;
      <td>0.34</td>&#13;
      <td>0.84</td>&#13;
      <td>0.21</td>&#13;
      <td>-2.39</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGqklEQVR4nO3dWYgcVRiG4bcyahKXjGsUBS1XcEHFBY0xJgrGpVwgIkRREgiIKAgiQumFeCFSoqAggghKDKIgimuhQtzikoi4IrmISspcuMR1oiZxGX8vzmmcdHoy093Tp6qs74FDVffMVP3T09/Uqe10ZGaISDNMK7sAEQlHgRdpEAVepEEUeJEGUeBFGkSBF2kQBV6kQRR4kQZR4EUaRIEXaRAFPrQo0rXMUpqdyi5ARMYXp/l8IAFOBdYCdxdZUvS6PAVepILiNN8JuANYCDwAPAbMA1YCR/S6XAVepGLiNJ8BvAB8BcwtsmSL/9KncZov72fZkW6PDSyKDLOo7DKkmuI0j4AVwLdFltw81cvXFl6kWm4BZgFLB7FwBV6kIuI0XwRcDswrsmR0EOtQlz40demlgzjNTwKeAhYUWbJhUOvReXiRksVpfiDwJHDlIMMOCrxIqeI03xV4FrityJI1g16fAi9SkjjNpwHLgZeLLHk8xDoVeJES+NNvd/mHt4dar47Si5TjVuBE4KIiS/4JtVIFXiQgv2W/CbgQWFhkyR8h16/AiwQSp/kQcC9wDHBhkSW/h65B+/AiAcRpPht4HhjGhX2kjDoUeJEBi9P8UuA9XOCXFlnyZ1m1qEsvMiBxmh8H3APMAM4rsmRdySUp8CJTLU7zk4EUOA53M8xzRZZU4hp2BV5kCsRpPh24DLgOmI47x754UDfB9EqBF+mRP8V2GrAEuAh4FbixyJL3Sy1sB3S3XGi6W6724jQ/GLgKuBr4BngUeLrIkt9KLWwStIUXmYQ4zXcHFuG25gfhxpg7v8iSr0otrEvawoemLXxt+P3yhcAVwFlAjtuar67KQbhuKfChKfCV5keLXYAL+XnAW8ATwCuhL4MdBAU+NAW+cuI0nwmcA1wMXAB8hAv5i2Vc/jpICnxoCnwlxGm+P+7I+sXAKcAq3NDQLxVZ8kuZtQ2SAh+aAl8KP7LMXNyW/BxgL9w++fPA20WW/FViecEo8KEp8EH4bvppuHCfDcTAu8Drvq2r64G3fijwoSnwU85fABMDc4DT/fQA4H1cuF8D1jYx4O0U+NAU+L74cB8KnIAbMeZE4CTgO2C1b2uA9Qr49hT40BT4SYnTfGfgENwHJx4OHI0L+RHABuAT4GM//ajIks0llVorCnxoCnxrtNZ9gAM7tENxoZ6J+zDFL3xbhwv451W7IaVOFPjQ/meB913sYVyA953EdG/cwCs/AF+3tW+A9cCXRZZsCvqLNIQCH1qFAu/DOhP34YXDbdOJntsTd2oLYBPwIy7EE01/LrLk78H/dtKJAh/aFAXeh3VXXACHcQEcnmSb5X8WYAsw4tsm30bapp3mR3DhDTbEsvSvr7vl4jT/DIiAP4GfcP/FW20j7shpq20EfqrSkVM/iuguuNdhsm2obX4I10UdmqBNA4YKt97r2762C24YpJkdpu3zewC7AQZs5r/w/dJhfj3bhnds21Klv4WE0e/tsfNxb7zpuH2zffhvX2027ujq/r7NBvaK03wU+B74GdjaobVuUIhwIRk7bc0PATvjgjK2TfRca7n4ukeBv3z727fRMfOd2uiY72nN/zNmfrzW+h78azX2a7/512Qrbou7o+kmYLPCKr3oq0sfRdE1ZvbQFNYzUHWrF+pXc93qhfrV3E+9/Q5TfU2fPx9a3eqF+tVct3qhfjX3XK/GpRdpEAVepEH6DXxt9nu8utUL9au5bvVC/WruuV6dhxdpEHXpRRqkq/PwURSdBZwBbDSzR6IoWoQ71/6FmT0ziAL71aHmJcCxwEtm9nq51W2vvV7/3IPAcjNbU2px4+jwGs/D3ZO+xsxWlVvd9jrUuwx3QRNmdl+pxY0jiqIFwLVmttg/Xoa7vuVNM3tnssvpdgs/x8wyYD//+Egzuxs4qsvlhLRNzWb2KPAgcFipVY1vm3r9P9U3Sq1oYu3vi0twFwpV9bLb9nqHcOHZWF5JO2Zmb+DuFmzZ18zuBM7sZjndBr59h78OBwC2qTGKot2AZcCKcsqZUPtrejzujzq3hFomq73mWWZ2P25M9ypqr3eamd2C663WRU/Z6+qgne8KzcFdN/8hboCCw4HPzezZXgoYtA4134C7v3qlma0us7ZO2us1sw98d25rxbv07e+LGBgxs4dLLK2jDvXOx11y/WtVr7iLougE4A7caD4rgHNxvZJV3XTpdZRepEF0lF6kQRR4kQZR4EUaRIEXaRAFXqRBFHiRBlHgRRpEgRdpEAVepEEUeJEGUeBFGuRfd6yBbimEh5UAAAAASUVORK5CYII="/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0409020S0AAAEAE&amp;denomIds=4.9.2&amp;selectedTab=summary" target="_blank">Procyclidine 5mg tablets : 30</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0602010V0&amp;denomIds=6.2.1&amp;selectedTab=summary">Levothyroxine sodium</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>2207</td>&#13;
      <td>Thyroid hormones</td>&#13;
      <td>2226</td>&#13;
      <td>0.99</td>&#13;
      <td>1.00</td>&#13;
      <td>0.00</td>&#13;
      <td>-2.38</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0602010V0AABWBW&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 25microgram tablets : 566</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0602010V0AABXBX&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 50microgram tablets : 636</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0602010V0AABYBY&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 75microgram tablets : 193</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0602010V0AABZBZ&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 100microgram tablets : 808</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0602010V0AAAFAF&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 50microgram capsules : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=0602010V0AAGHGH&amp;denomIds=6.2.1&amp;selectedTab=summary" target="_blank">Levothyroxine sodium 12.5microgram tablets : 3</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1501030G0&amp;denomIds=15.1.3&amp;selectedTab=summary">Glycopyrronium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Antimuscarinic drugs</td>&#13;
      <td>1</td>&#13;
      <td>0.00</td>&#13;
      <td>0.82</td>&#13;
      <td>0.36</td>&#13;
      <td>-2.30</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1108010F0&amp;denomIds=11.8.1&amp;selectedTab=summary">Hypromellose</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>33</td>&#13;
      <td>Tear deficiency, eye lubricant/astringent</td>&#13;
      <td>215</td>&#13;
      <td>0.15</td>&#13;
      <td>0.45</td>&#13;
      <td>0.15</td>&#13;
      <td>-1.97</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1108010F0AAAAAA&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Hypromellose 0.3% eye drops : 30</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H81615&amp;numIds=1108010F0BDAAA4&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Tears Naturale eye drops : 3</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>